The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2
Published version of a preprint
Abstract
Conformational selection by small molecules expands inhibitory possibilities for protein kinases. Nuclear magnetic resonance (NMR) measurements of the mitogen-activated protein (MAP) kinase ERK2 have shown that activation by dual phosphorylation induces global motions involving exchange between two states, L and R. We show that ERK inhibitors Vertex-11e and SCH772984 exploit the small energetic difference between L and R to shift the equilibrium in opposing directions. An X-ray structure of active 2P-ERK2 complexed with AMP-PNP reveals a shift in the Gly-rich loop along with domain closure to position the nucleotide in a more catalytically productive conformation relative to inactive 0P-ERK2:ATP. X-ray structures of 2P-ERK2 complexed with Vertex-11e or GDC-0994 recapitulate this closure, which is blocked in a complex with a SCH772984 analog. Thus, the L→R shift in 2P-ERK2 is associated with movements needed to form a competent active site. Solution measurements by hydrogen-exchange mass spectrometry (HX-MS) reveal distinct binding interactions for Vertex-11e, GDC-0994, and AMP-PNP with active vs. inactive ERK2, where the extent of HX protection correlates with R state formation. Furthermore, Vertex-11e and SCH772984 show opposite effects on HX near the activation loop. Consequently, these inhibitors differentially affect MAP kinase phosphatase activity toward 2P-ERK2. We conclude that global motions in ERK2 reflect conformational changes at the active site that promote productive nucleotide binding and couple with changes at the activation loop to allow control of dephosphorylation by conformationally selective inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Well-tuned conformational dynamics for protein kinases not only are essential for the catalytically important loops (10, 29, 44, 47–53), but it is also a requirement for the hydrophobic C- and R-spines of kinases (33), for which a single mutation leads to complete inactivation of the enzyme (11).”
From Atp-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy (2022) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., & Goldsmith, E. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80351-7 · Cited by 729
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0070 · Cited by 676
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592
Circumventing cancer drug resistance in the era of personalized medicine
Garraway, L. A., & Jänne, P. A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0012 · Cited by 503 · cited 5×
“The prevalence of oncogenic BRAF mutations in melanoma and other cancers has led to the development of inhibitors targeting BRAF-V600E/K and MKK1/2 (1).”
BackgroundInfluentialDefining a new nomenclature for the structures of active and inactive kinases
Modi, V., & Dunbrack, R. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814279116 · Cited by 367
Docking Motif Interactions in MAP Kinases Revealed by Hydrogen Exchange Mass Spectrometry
Lee, T., Hoofnagle, A. N., Kabuyama, Y., Stroud, J., Min, X., Goldsmith, E. J., Chen, L., Resing, K. A., & Ahn, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00161-3 · Cited by 282 · cited 1×
“Other conformational changes include a small rotation and closure between N- and C-terminal domains and exposure of a docking motif binding site below the activation loop (4-6).”
BackgroundSelf-citationTowards simple kinetic models of functional dynamics for a kinase subfamily
Sultan, M. M., Kiss, G., & Pande, V. S. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0077-9 · Cited by 68 · cited 1×
“Likewise, activation loop dynamics have been suggested by simulations of the Fyn tyrosine kinase domain (31).”
Background
Research works printed but not linked: 29
- K. Burkhard, S. Smith, R. Deshmukh, A. D. MacKerellJr, P. Shapiro, Development of extracellular signal-regulated kinase inhibitors. Curr. Top. Med. Chem. 9, 678–689 (2009). · DOI
- M. B. Ryan, C. J. Der, A. Wang-Gillam, A. D. Cox, Targeting RAS-mutant cancers: Is ERK the key? Trends Cancer 1, 183–198 (2015). · DOI
- M. Huse, J. Kuriyan, The conformational plasticity of protein kinases. Cell 109, 275–282 (2002). · DOI · Paper page
- A. N. Hoofnagle, K. A. Resing, E. J. Goldsmith, N. G. Ahn, Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. Proc. Natl. Acad. Sci. U.S.A. 98, 956–961 (2001). · DOI
- Y. Xiao, J. C. Liddle, A. Pardi, N. G. Ahn, Dynamics of protein kinases: Insights from nuclear magnetic resonance. Acc. Chem. Res. 48, 1106–1114 (2015). · DOI
- Y. Xiao ., Phosphorylation releases constraints to domain motion in ERK2. Proc. Natl. Acad. Sci. U.S.A. 111, 2506–2511 (2014). · DOI · Paper page
- A. M. Aronov ., Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control. J. Med. Chem. 52, 6362–6368 (2009). · DOI
- J. Rudolph, Y. Xiao, A. Pardi, N. G. Ahn, Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors. Biochemistry 54, 22–31 (2015). · DOI
- T. Lee, A. N. Hoofnagle, K. A. Resing, N. G. Ahn, Hydrogen exchange solvent protection by an ATP analogue reveals conformational changes in ERK2 upon activation. J. Mol. Biol. 353, 600–612 (2005). · DOI
- K. M. Sours, Y. Xiao, N. G. Ahn, Extracellular-regulated kinase 2 is activated by the enhancement of hinge flexibility. J. Mol. Biol. 426, 1925–1935 (2014). · DOI · Paper page
- Z. Zhao ., Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery? ACS Chem. Biol. 9, 1230–1241 (2014). · DOI · Paper page
- J. F. Blake ., Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor in early clinical development. J. Med. Chem. 59, 5650–5660 (2016). · DOI
- M. J. Knape, F. W. Herberg, Metal coordination in kinases and pseudokinases. Biochem. Soc. Trans. 45, 653–663 (2017). · DOI
- J. Zhang, P. Shapiro, E. Pozharski, Structure of extracellular signal-regulated kinase 2 in complex with ATP and ADP. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68, 1434–1439 (2012). · DOI
- B. C. Lechtenberg ., Structure-guided strategy for the development of potent bivalent ERK inhibitors. ACS Med. Chem. Lett. 8, 726–731 (2017). · DOI
- K. Smorodinsky-Atias ., Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation. Mol. Biol. Cell 27, 1026–1039 (2016). · DOI
- D. Barr ., Importance of domain closure for the autoactivation of ERK2. Biochemistry 50, 8038–8048 (2011). · DOI
- A. Chaikuad ., A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics. Nat. Chem. Biol. 10, 853–860 (2014). · DOI · Paper page
- H. Maity, W. K. Lim, J. N. Rumbley, S. W. Englander, Protein hydrogen exchange mechanism: Local fluctuations. Protein Sci. 12, 153–160 (2003). · DOI
- J. Basken ., Specificity of phosphorylation responses to mitogen activated protein (MAP) kinase pathway inhibitors in melanoma cells. Mol. Cell. Proteomics 17, 550–564 (2018). · DOI
- Y. Zhao, Z. Y. Zhang, The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3. J. Biol. Chem. 276, 32382–32391 (2001). · DOI · Paper page
- W. F. Waas, K. N. Dalby, Physiological concentrations of divalent magnesium ion activate the serine/threonine specific protein kinase ERK2. Biochemistry 42, 2960–2970 (2003). · DOI
- P. Strop, S. L. Mayo, Contribution of surface salt bridges to protein stability. Biochemistry 39, 1251–1255 (2000). · DOI · Paper page
- P. Roser, J. Weisner, J. R. Simard, D. Rauh, M. Drescher, Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38α. Chem. Commun. (Camb.) 54, 12057–12060 (2018). · DOI
- J. A. H. Gilburt ., Dynamic equilibrium of the Aurora A kinase activation loop revealed by single-molecule spectroscopy. Angew. Chem. Int. Ed. Engl. 56, 11409–11414 (2017). · DOI
- E. F. Ruff ., A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation. eLife 7, e32766 (2018). · DOI
- J. A. H. Gilburt, P. Girvan, J. Blagg, L. Ying, C. A. Dodson, Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylation. Chem. Sci. (Camb.) 10, 4069–4076 (2019). · doi:10.1039/c8sc03669a
- E. W. Lake ., Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states. Proc. Natl. Acad. Sci. U.S.A. 115, E11894–E11903 (2018).
- S. B. Hari, E. A. Merritt, D. J. Maly, Conformation-selective ATP-competitive inhibitors control regulatory interactions and noncatalytic functions of mitogen-activated protein kinases. Chem. Biol. 21, 628–635 (2014). · DOI
Cited by
Olivieri, C., Li, G. C., Wang, Y., V.S., M., Walker, C., Kim, J., Camilloni, C., De Simone, A., Vendruscolo, M., Bernlohr, D. A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0696 · Cited by 60
Metadata
- Authors
- Pegram, L. M., Liddle, J. C., Xiao, Y., Hoh, M., Rudolph, J., Iverson, D. B., Vigers, G. P., Smith, D., Zhang, H., Wang, W., Moffat, J. G., & Ahn, N. G.
- Affiliations
- Department of Biochemistry, University of Colorado, Boulder, CO 80305;
- Structural Biology Group, Array BioPharma Inc., Boulder, CO 80301;
- Structural Biology and Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA 94080
- ORCID
- Ahn, Natalie G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-07-16
- Volume
- 116
- Issue
- 31
- Pages
- 15463-15468
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 46
- References
- 7
- Language
- en
- Funders
- HHS | NIH | National Institute of General Medical Sciences (R01GM114594, T32GM08759)
- HHS | National Institutes of Health (S10RR026641)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. https://app.cochat.ai/papers/10.1073/pnas.1906824116
- The paper
- Pegram, L. M., Liddle, J. C., Xiao, Y., Hoh, M., Rudolph, J., Iverson, D. B., Vigers, G. P., Smith, D., Zhang, H., Wang, W., Moffat, J. G., & Ahn, N. G. (2019). Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1906824116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.